Centocor, Inc.'s Psoriasis Drug May Ease Psoriatic Arthritis, Tufts University Study

Published: Feb 13, 2009

BOSTON (Feb. 11, 2009) – A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA). The Phase 2 study was published in the British medical journal The Lancet.

Back to news